News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
FDA awards Neuralert Technologies Breakthrough Device designation
The Center for Devices and Radiological Health (CDRH) of the FDA has granted the Neuralert Monitor designation as a Breakthrough Device.
New engineering approaches to address unmet oral health needs
With a new NIH training grant, awards, and new faculty and publications, the recently launched Center for Innovation & Precision Dentistry is leveraging technological advancements to improve oral heal
Philadelphia-area VC funding smashes annual record just halfway through 2021
Philadelphia-area firms raised $3.1 billion in venture capital funding during the first half of 2021, already smashing an annual record set two years ago.
Introducing the 2021 Pennovation Accelerator Eco-Impact Cohort
The 2021 Pennovation Accelerator officially launched Monday, July 12th for the program's fourth summer!
Regional collaborations emerge to address the biomanufacturing workforce crisis
In Philadelphia alone, cell and gene therapy and gene editing companies are preparing to add more than 1,100 new employees per year for the next decade, a net gain of more than 6,000 new workers.
Low-cost Electrochemical Advanced Diagnostic COVID test research published in PNAS
Latest research by Penn Medicine's Cesar de la Fuente, PhD, on the low cost COVID test in the Proceedings of the National Academy of Sciences:
Latest ‘organ-on-a-chip’ is a new way to study cancer-related muscle wasting
Studying drug effects on human muscles just got easier thanks to a new “muscle-on-a-chip,” developed by a team of researchers from Penn’s School of Engineering and Applied Science and Inha University